32 results on '"Peppe, J."'
Search Results
2. SAR Interferometry Data Exploitation for Infrastructure Monitoring Using GIS Application
- Author
-
Felipe Orellana, Peppe J. V. D’Aranno, Silvia Scifoni, and Maria Marsella
- Subjects
infrastructure monitoring ,DInSAR ,GIS ,ERS ,Envisat ,COSMO-SkyMed ,Technology - Abstract
Monitoring structural stability in urban areas and infrastructure networks is emerging as one of the dominant socio-economic issues for population security. The problem is accentuated by the age of the infrastructure because of increasing risks due to material deterioration and loss of load capacity. In this case, SAR satellite data are crucial to identify and assess the deteriorating conditions of civil infrastructures. The large amount of data available from SAR satellite sensors leads to the exploitation and development of new GIS-based procedures for rapid responses and decision making. In recent decades, the DInSAR technique has been used efficiently for the monitoring of structures, providing measurement points located on structures with millimeter precision. Our study has analyzed the behavior of structures in settlements, attempting to discuss the interactions of soil and structures, and examining the behavior of different types of structures, such as roads and buildings. The method used is based on long-term SAR interferometry data and a semi-automatic procedure to measure the displacement (mm/year) of structures, through a GIS-based application performed in the “Implemented MOnitoring DIsplacement” I.MODI platform. The analysis provides extensive information on long-term spatial and temporal continuity of up to 25 years of record, using satellite SAR multi-sensors from ERS, Envisat, and COSMO-SkyMed. The interpretation uses time series spatial analysis, supported by orthophotos, and layers of the DBTR (regional topographic database), Digital Surface model (DSM), and hydrogeological map to show anomalous areas with a high displacement rate and to observe the correlation of settlements in the sediments. With the satellite information and Geographic Information System (GIS), we were able to observe relevant parameters, such as the velocity of advance in the direction of the slope (deformation profiles), the cumulative displacement, and the trend changes in structures. The results illustrate an innovative procedure that allows the management of DInSAR data to facilitate the effective management of structures in which a monitoring protocol was developed at different spatial scales, integrating the information into a GIS.
- Published
- 2023
- Full Text
- View/download PDF
3. SAR Interferometry Data Exploitation for Infrastructure Monitoring Using GIS Application
- Author
-
Orellana, Felipe, primary, D’Aranno, Peppe J. V., additional, Scifoni, Silvia, additional, and Marsella, Maria, additional
- Published
- 2023
- Full Text
- View/download PDF
4. High-resolution geomatic and geophysical techniques integrated with chemical analyses for the characterization of a Roman wall
- Author
-
V. D’Aranno, Peppe J., De Donno, Giorgio, Marsella, Maria, Orlando, Luciana, Renzi, Beatrice, Salviani, Silvia, Santarelli, Maria Laura, Scifoni, Silvia, Sonnessa, Alberico, Verri, Francesca, and Volpe, Rita
- Published
- 2016
- Full Text
- View/download PDF
5. An Application of Persistent Scatterer Interferometry (PSI) Technique for Infrastructure Monitoring
- Author
-
Peppe J. V. D’Aranno, Alessandro Di Benedetto, Margherita Fiani, Maria Marsella, Ilaria Moriero, and José Antonio Palenzuela Baena
- Subjects
SAR ,interferometry ,PSI ,ERS1/2 ,ENVISAT ,COSMO-SkyMed ,Science - Abstract
In the absence of systematic structural monitoring to support adequate maintenance standards, many existing infrastructures may reach unacceptable quality levels during their life cycle, resulting in significant damage and even potential failure. The metropolitan area of the Gulf of Salerno (Italy), served by a complex multimodal transport network connecting the port area to the roads and railways surrounding the urban area, represents an important industrial and commercial hub at the local and international scale. This particular scenario, developed in a complex morphological and geological context, has led to the interference and overlapping of the transport network (highway, railway, main and secondary roads) that run through the piedmont area north of the port. Given the relevance of the area, our research aims to highlight the capabilities of the persistent scatterer interferometry (PSI) technique, belonging to the group of differential interferometric synthetic aperture radar (SAR), to extract space–temporal series of displacements on ground points or artifacts with millimeter accuracy useful to understand ongoing deformation processes. By using archived data from the European Space Agency missions, i.e., ERS1/2 (European remote-sensing satellite) and ENVISAT (environmental satellite), and the most recent data from COSMO-SkyMed constellations, it was possible to collect a 28-year dataset that was used to spatially analyze displacement patterns at a site-specific scale to check the stability of viaducts and embankments, and on a larger scale to understand the activity of the surrounding slopes. Despite the different resolution and subsequently the ground density, the analysis of the different datasets showed a spatiotemporal consistency in the displacement patterns that concerned two subareas showing significant annual velocity trends, one northeast of the city and the second in the port area. The analysis presented in this paper highlights how a complex geologic area, combining slope movements and various fault systems, could be a major concern for the stability of the overlying infrastructure and also the role that a PSI analysis can play in remotely monitoring their behavior over long periods of time.
- Published
- 2021
- Full Text
- View/download PDF
6. P1051: A PHASE 2 STUDY OF IMG-7289 (BOMEDEMSTAT) IN PATIENTS WITH ADVANCED MYELOFIBROSIS
- Author
-
Gill, H., primary, Yacoub, A., additional, Pettit, K., additional, Bradley, T., additional, Gerds, A., additional, Tatarczuch, M., additional, Shortt, J., additional, Curtin, N., additional, Rossetti, J., additional, Burbury, K., additional, Mead, A., additional, Göthert, J., additional, Koschmieder, S., additional, Jones, A., additional, Peppe, J., additional, Dias, J., additional, Natsoulis, G., additional, McClure, T., additional, Kleppe, M., additional, Hong, W.-J., additional, Stevenson, W., additional, Ewing, J., additional, Chacko, J., additional, Rumi, E., additional, Halpern, A., additional, Palandri, F., additional, Vianelli, N., additional, Passamonti, F., additional, Mesa, R., additional, Marchetti, M., additional, Harrison, C., additional, Vannucchi, A., additional, Watts, J., additional, Ross, D., additional, Talpaz, M., additional, and Rienhoff, H., additional
- Published
- 2022
- Full Text
- View/download PDF
7. P1033: A PHASE 2 STUDY OF THE LSD1 INHIBITOR IMG-7289 (BOMEDEMSTAT) FOR THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA (ET)
- Author
-
Palandri, F., primary, Ross, D. M., additional, Cochrane, T., additional, Tate, C., additional, Lane, S. W., additional, Larsen, S. R., additional, Gerds, A. T., additional, Halpern, A. B., additional, Shortt, J., additional, Rossetti, J. M., additional, Pettit, K. M., additional, Liang, J., additional, Mead, A., additional, Marchetti, M., additional, Vannucchi, A., additional, Wilson, A., additional, Göthert, J. R., additional, Hanna, M., additional, Jones, A., additional, Peppe, J., additional, Natsoulis, G., additional, McClure, T., additional, Hong, W.-J., additional, Stevenson, W. S., additional, Harrison, C. N., additional, Talpaz, M., additional, Vianelli, N., additional, and Rienhoff, H. Y., additional
- Published
- 2022
- Full Text
- View/download PDF
8. Terrestrial laser scanning survey in support of unstable slopes analysis: the case of Vulcano Island (Italy)
- Author
-
Marsella, Maria, D’Aranno, Peppe J. V., Scifoni, Silvia, Sonnessa, Alberico, and Corsetti, Marco
- Published
- 2015
- Full Text
- View/download PDF
9. Advanced DInSAR analysis for building damage assessment in large urban areas: an application to the city of Roma, Italy.
- Author
-
Peppe J. V. D'Aranno, Maria Marsella, Silvia Scifoni, Marianna Scutti, Alberico Sonnessa, and Manuela Bonano
- Published
- 2015
- Full Text
- View/download PDF
10. The Use of Surveillance Cameras for the Rapid Mapping of Lava Flows: An Application to Mount Etna Volcano
- Author
-
Mauro Coltelli, Peppe J. V. d’Aranno, Roberto de Bonis, Josè F. Guerrero Tello, Maria Marsella, Carla Nardinocchi, Emilio Pecora, Cristina Proietti, Silvia Scifoni, Marianna Scutti, and Wissam Wahbeh
- Subjects
volcano monitoring ,lava flow mapping ,surveillance camera ,hazard assessment ,geo spatial dataset ,Science - Abstract
In order to improve the observation capability in one of the most active volcanic areas in the world, Mt. Etna, we developed a processing method to use the surveillance cameras for a quasi real-time mapping of syn-eruptive processes. Following an evaluation of the current performance of the Etna permanent ground NEtwork of Thermal and Visible Sensors (Etna_NETVIS), its possible implementation and optimization was investigated to determine the locations of additional observation sites to be rapidly set up during emergencies. A tool was then devised to process time series of ground-acquired images and extract a coherent multi-temporal dataset of georeferenced map. The processed datasets can be used to extract 2D features such as evolution maps of active lava flows. The tool was validated on ad-hoc test fields and then adopted to map the evolution of two recent lava flows. The achievable accuracy (about three times the original pixel size) and the short processing time makes the tool suitable for rapidly assessing lava flow evolutions, especially in the case of recurrent eruptions, such as those of the 2011–2015 Etna activity. The tool can be used both in standard monitoring activities and during emergency phases (eventually improving the present network with additional mobile stations) when it is mandatory to carry out a quasi-real-time mapping to support civil protection actions. The developed tool could be integrated in the control room of the Osservatorio Etneo, thus enabling the Etna_NETVIS for mapping purposes and not only for video surveillance.
- Published
- 2017
- Full Text
- View/download PDF
11. A Phase 2 Study of the LSD1 Inhibitor Img-7289 (bomedemstat) for the Treatment of Advanced Myelofibrosis.
- Author
-
Gill H., Yacoub A., Pettit K.M., Bradley T., Gerds A.T., Tatarczuch M., Shortt J., Curtin N.J., Rossetti J.M., Burbury K., Mead A.J., Gothert J.R., Koschmieder S., Jones A., Peppe J., Natsoulis G., Hong W.-J., Stevenson W.S., Ewing J., Harrison C.N., Vannucchi A., Watts J., Ross D.M., Talpaz M., Rienhoff H.Y., Gill H., Yacoub A., Pettit K.M., Bradley T., Gerds A.T., Tatarczuch M., Shortt J., Curtin N.J., Rossetti J.M., Burbury K., Mead A.J., Gothert J.R., Koschmieder S., Jones A., Peppe J., Natsoulis G., Hong W.-J., Stevenson W.S., Ewing J., Harrison C.N., Vannucchi A., Watts J., Ross D.M., Talpaz M., and Rienhoff H.Y.
- Abstract
[Formula presented] There is an unmet need for novel therapies with distinct modes of action to offer clinical benefit for patients with myelofibrosis (MF) who become resistant or intolerant to JAK inhibitors. Lysine-specific demethylase-1 (LSD1) is a histone demethylase critical for self-renewal potential of malignant myeloid cells for hematopoietic differentiation, e.g., LSD1 licenses maturation of megakaryocytes, one cell type critical to the pathogenesis of MF. Bomedemstat is an orally active LSD1 inhibitor that in mouse models of MPNs reduced peripheral cell counts, splenomegaly, inflammatory cytokines, marrow fibrosis, mutant cell burden and overall survival (Jutzi et al. 2018). IMG-7289-CTP-102 is a global, open-label Phase 1/2 study evaluating bomedemstat dosed once daily in MF patients (NCT03136185). Data from this ongoing study are presented. Key eligibility criteria include IPSS int.-1 or -2 or high-risk patients refractory or resistant to, inadequately controlled by or intolerant of available approved therapy, or in the Investigator's judgment, are not candidates for available approved therapy, peripheral blast count <=10%, absolute neutrophil count >=0.5 x 10 9/L, and platelet count >=100 x 10 9/L. Key objectives are safety and reduction of spleen volume (SVR) by MRI/CT and total symptoms scores (TSS) using the MPN-SAF instrument. Serial bone marrow (BM) biopsies and imaging studies are read centrally. Of 261 genes recurrently mutated in AML/MPN/MDS, germline and somatic baseline and follow-up sequencing is conducted to quantify existing or new mutant alleles frequencies (MAF). Dosing is individually tailored using platelet count as a biomarker of bomedemstat activity on megakaryocyte function, targeting a range between 50-100 x 10 9/L and titrating as needed. At data cutoff (15 July 2021), the study is fully enrolled with 89 patients: 49% primary MF, 30% post-essential thrombocythemia-MF, 21% post-polycythemia vera-MF. Median age is 68 (35-88) with 52%
- Published
- 2021
12. A phase 2 study of the lsd1 inhibitor img- 7289 (bomedemstat) for the treatment of essential thrombocythemia (et).
- Author
-
Ross D., Cochrane T., Lane S., Larsen S., Gerds A., Halpern A., Shortt J., Rossetti J., Jones A., Peppe J., Natsoulis G., Stevenson W., Vianetti N., Harrison C., Rienhoff H., Ross D., Cochrane T., Lane S., Larsen S., Gerds A., Halpern A., Shortt J., Rossetti J., Jones A., Peppe J., Natsoulis G., Stevenson W., Vianetti N., Harrison C., and Rienhoff H.
- Abstract
Background: For patients with essential thrombocythaemia (ET) intolerant of or resistant to hydroxyurea (HU), interferon or anagrelide, there is a need for therapies with distinct MOAs that reduce thromboses, improve the patient experience and potentially offer distinct clinical benefits. Lysine-specific demethylase-1 (LSD1) is a histone H3K4 demethylase critical for the self-renewal potential of malignant myeloid cells and the differentiation of myeloid progenitors, e.g., LSD1 licenses progenitors to mature into megakaryocytes, a cell central to the pathogenesis of ET. IMG-7289 (bomedemstat) is an orally active LSD1 inhibitor that reduced peripheral cell counts, splenomegaly, inflammatory cytokines, and mutant cell burdens in mouse models of MPNs (Jutzi et al. 2018). In an ongoing study of IMG-7289 for the treatment of myelofibrosis (MF) (NCT03136185), symptoms, platelets, neutrophils, mutant allele burdens and inflammatory cytokines were favorably impacted (Pettit et al. 2020). Aim(s): IMG-7289-CTP-201 is an ongoing, multi-national, open-label, 24-week Phase 2b study of bomedemstat taken once daily in patients with ET who are resistant to or intolerant of at least one standard of care treatment (NCT04254978). Key objectives are safety and reduction in the platelet count to <=400k/muL in the absence of thromboembolic events. Dosing is individually tailored targeting a platelet count between 200- 400k/muL. All patients were started at a dose of 0.6mg/kg/d and titrated as needed to the target platelet count range. Method(s): At the censoring date (16 Feb 2021), 10 patients had enrolled. All patients remain on study. The median duration of treatment is 85 days (6-141). Median age, 66 years (55-84), 20% males. 60% were deemed resistant to or intolerant of HU (by ELN criteria), 20% to anagrelide and 10% to interferon or busulfan. 40% had received at least one additional previous treatment. After a 14- to 28-day washout of prior ET treatment, the mean platelet and WBC co
- Published
- 2021
13. An Application of Persistent Scatterer Interferometry (PSI) Technique for Infrastructure Monitoring
- Author
-
D’Aranno, Peppe J. V., primary, Di Benedetto, Alessandro, additional, Fiani, Margherita, additional, Marsella, Maria, additional, Moriero, Ilaria, additional, and Palenzuela Baena, José Antonio, additional
- Published
- 2021
- Full Text
- View/download PDF
14. A phase 2 study of bomedemstat (IMG-7289), a lysine-specific demethylase-! (LSD!) inhibitor, for the treatment of later-stage myelofibrosis (MF).
- Author
-
Shortt J., Jones A., Peppe J., Stevenson W., Yacoub A., Gerds A., Bradley T., Tatarczuch M., Curtin N., Rossetti J., Mead A., Harrison C., Vannucchi A., Watts J., Ross D., Talpaz M., Rienhoff H., Ewing J., Burbury K., Pettit K., Shortt J., Jones A., Peppe J., Stevenson W., Yacoub A., Gerds A., Bradley T., Tatarczuch M., Curtin N., Rossetti J., Mead A., Harrison C., Vannucchi A., Watts J., Ross D., Talpaz M., Rienhoff H., Ewing J., Burbury K., and Pettit K.
- Abstract
Background: Myelofibrosis is caused by constitutive activation of the JAK/STAT pathway. JAK inhibitors reduce spleen volume and improve symptoms, but disease progression through JAK inhibition underscores the need for therapies with distinct modes of action. Bomedemstat (IMG-7289) is an inhibitor of lysine-specific demethylase-1 (LSD1), an epigenetic regulator critical for self-renewal of malignant myeloid cells and for the differentiation of myeloid progenitors. LSD1 with GFI1b licenses maturation of progenitors to megakaryocytes and enables their normal function. In mouse models of MPNs (MplW515L, JAK2V617F), LSD1 inhibition improved peripheral cell counts, spleen volumes, inflammatory cytokines, mutant allele frequencies, and marrow fibrosis (Jutzi et al. 2018). Aim(s): This multi-center, open-label Phase 2 study evaluated the safety and pharmacodynamics of bomedemstat administered orally once-daily in adult patients with high or intermediate-2 risk MF who were resistant to or intolerant of ruxolitinib. Method(s): The primary objectives were safety, PK and spleen volume (SV) reduction. Other endpoints included changes in total symptom scores (TSS), bone marrow (BM) fibrosis and inflammatory cytokines. Key inclusion criteria included platelet count >=100K/muL. Patients in the doserange finding study (N = 18) were treated daily for 12 weeks followed by a washout period of up to 28 days. Patients in the Phase 2b study (N = 16) were treated daily for 24 weeks. Abdominal imaging to measure SV was performed after every 12 weeks of treatment. The MPN10 responses were submitted at each clinic visit. Dosing was tailored using platelet count as a marker of bomedemstat activity on megakaryocyte function. Phase 2a patients started at the presumed sub-therapeutic dose of 0.25 mg/kg/d and were up-titrated weekly until the platelet count rested between 50 and 100K/muL. Phase 2b patients started at 0.5 mg/kg/d and were up-titrated until platelet counts rested between 50 and 75K
- Published
- 2020
15. Results of a phase III trial comparing tolevamer, vancomycin and metronidazole in patients with Clostridium difficile-associated diarrhoea: O464
- Author
-
Bouza, E., Dryden, M., Mohammed, R., Peppe, J., Chasan-Taber, S., Donovan, J., Davidson, D., and Short, G.
- Published
- 2008
16. A randomised, double-blind, placebo-controlled, parallel-design trial of multiple doses of tolevamer in healthy male volunteers: P1579
- Author
-
Davidson, D., Porzio, A., Nealon, P., and Peppe, J.
- Published
- 2005
17. A phase 2 study of the toxin binding polymer tolevamer in patients with C. difficile associated diarrhoea
- Author
-
Davidson, D., Peppe, J., and Louie, T.
- Published
- 2004
18. S832 A PHASE 2A STUDY OF THE LSD1 INHIBITOR IMG-7289 FOR THE TREATMENT OF MYELOFIBROSIS
- Author
-
Pettit, K., primary, Curtin, N., additional, Tartaczuch, M., additional, Shortt, J., additional, Watts, J., additional, Stevenson, W., additional, Gerds, A., additional, Burbury, K., additional, Yacoub, A., additional, Jones, A., additional, Peppe, J., additional, Ross, D.M., additional, and Rienhoff, H.Y., additional
- Published
- 2019
- Full Text
- View/download PDF
19. Advanced DInSAR analysis for building damage assessment in large urban areas: an application to the city of Roma, Italy
- Author
-
D'Aranno, Peppe J. V., additional, Marsella, Maria, additional, Scifoni, Silvia, additional, Scutti, Marianna, additional, Sonnessa, Alberico, additional, and Bonano, Manuela, additional
- Published
- 2015
- Full Text
- View/download PDF
20. The Use of Surveillance Cameras for the Rapid Mapping of Lava Flows: An Application to Mount Etna Volcano.
- Author
-
Coltelli, Mauro, d’Aranno, Peppe J. V., de Bonis, Roberto, Guerrero Tello, Josè F., Marsella, Maria, Nardinocchi, Carla, Pecora, Emilio, Proietti, Cristina, Scifoni, Silvia, Scutti, Marianna, and Wahbeh, Wissam
- Subjects
- *
VOLCANOES , *TELEVISION in security systems , *LAVA flows , *GEOSPATIAL data - Abstract
In order to improve the observation capability in one of the most active volcanic areas in the world, Mt. Etna, we developed a processing method to use the surveillance cameras for a quasi real-time mapping of syn-eruptive processes. Following an evaluation of the current performance of the Etna permanent ground NEtwork of Thermal and Visible Sensors (Etna_NETVIS), its possible implementation and optimization was investigated to determine the locations of additional observation sites to be rapidly set up during emergencies. A tool was then devised to process time series of ground-acquired images and extract a coherent multi-temporal dataset of georeferenced map. The processed datasets can be used to extract 2D features such as evolution maps of active lava flows. The tool was validated on ad-hoc test fields and then adopted to map the evolution of two recent lava flows. The achievable accuracy (about three times the original pixel size) and the short processing time makes the tool suitable for rapidly assessing lava flow evolutions, especially in the case of recurrent eruptions, such as those of the 2011–2015 Etna activity. The tool can be used both in standard monitoring activities and during emergency phases (eventually improving the present network with additional mobile stations) when it is mandatory to carry out a quasi-real-time mapping to support civil protection actions. The developed tool could be integrated in the control room of the Osservatorio Etneo, thus enabling the Etna_NETVIS for mapping purposes and not only for video surveillance. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
21. Advanced DInSAR analysis for building damage assessment in large urban areas: an application to the city of Roma, Italy
- Author
-
Notarnicola, Claudia, Paloscia, Simonetta, Pierdicca, Nazzareno, D'Aranno, Peppe J. V., Marsella, Maria, Scifoni, Silvia, Scutti, Marianna, Sonnessa, Alberico, and Bonano, Manuela
- Published
- 2015
- Full Text
- View/download PDF
22. An Application of Persistent Scatterer Interferometry (PSI) Technique for Infrastructure Monitoring.
- Author
-
D'Aranno, Peppe J. V., Di Benedetto, Alessandro, Fiani, Margherita, Marsella, Maria, Moriero, Ilaria, Palenzuela Baena, José Antonio, and Pfeffer, Karin
- Subjects
- *
INTERFEROMETRY , *SYNTHETIC aperture radar , *STRUCTURAL health monitoring , *METROPOLITAN areas , *CITIES & towns - Abstract
In the absence of systematic structural monitoring to support adequate maintenance standards, many existing infrastructures may reach unacceptable quality levels during their life cycle, resulting in significant damage and even potential failure. The metropolitan area of the Gulf of Salerno (Italy), served by a complex multimodal transport network connecting the port area to the roads and railways surrounding the urban area, represents an important industrial and commercial hub at the local and international scale. This particular scenario, developed in a complex morphological and geological context, has led to the interference and overlapping of the transport network (highway, railway, main and secondary roads) that run through the piedmont area north of the port. Given the relevance of the area, our research aims to highlight the capabilities of the persistent scatterer interferometry (PSI) technique, belonging to the group of differential interferometric synthetic aperture radar (SAR), to extract space–temporal series of displacements on ground points or artifacts with millimeter accuracy useful to understand ongoing deformation processes. By using archived data from the European Space Agency missions, i.e., ERS1/2 (European remote-sensing satellite) and ENVISAT (environmental satellite), and the most recent data from COSMO-SkyMed constellations, it was possible to collect a 28-year dataset that was used to spatially analyze displacement patterns at a site-specific scale to check the stability of viaducts and embankments, and on a larger scale to understand the activity of the surrounding slopes. Despite the different resolution and subsequently the ground density, the analysis of the different datasets showed a spatiotemporal consistency in the displacement patterns that concerned two subareas showing significant annual velocity trends, one northeast of the city and the second in the port area. The analysis presented in this paper highlights how a complex geologic area, combining slope movements and various fault systems, could be a major concern for the stability of the overlying infrastructure and also the role that a PSI analysis can play in remotely monitoring their behavior over long periods of time. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
23. A Phase 2a Study of the LSD1 Inhibitor Img-7289 (bomedemstat) for the Treatment of Myelofibrosis.
- Author
-
Pettit K., Gerds A.T., Yacoub A., Watts J.M., Tartaczuch M., Bradley T.J., Shortt J., Stevenson W.S., Curtin N.J., Rossetti J.M., Burbury K., Natsoulis G., Jones A., Talpaz M., Peppe J., Ross D.M., Rienhoff H.Y., Pettit K., Gerds A.T., Yacoub A., Watts J.M., Tartaczuch M., Bradley T.J., Shortt J., Stevenson W.S., Curtin N.J., Rossetti J.M., Burbury K., Natsoulis G., Jones A., Talpaz M., Peppe J., Ross D.M., and Rienhoff H.Y.
- Abstract
Ruxolitinib (Jakafi) is the one approved therapy for myelofibrosis (MF) based on reduction of splenomegaly and symptoms but JAK inhibition has not proven to significantly modify disease progression. There remains the need for novel therapies with distinct modes of action that can improve the patient experience of MF and impact progression. Lysine-specific demethylase, LSD1, is an epigenetic enzyme critical for self-renewal of malignant myeloid cells and differentiation of myeloid progenitors. LSD1 bound to GFI1b permits maturation of progenitors to megakaryocytes and enables their normal function. IMG-7289 (bomedemstat) is an orally available LSD1 inhibitor. In mouse models of myeloproliferative neoplasms (MPN), IMG-7289 reduced elevated peripheral cell counts, spleen size, inflammatory cytokines, mutant allele frequencies, and marrow fibrosis (Jutzi et al. 2018) supporting its clinical development. IMG-7289-CTP-102 is an ongoing, multi-center, open-label study that recently transitioned from a Phase 1/2a dose-range finding study to a Phase 2b study of IMG-7289 administered orally once-daily in adult patients with intermediate-2 or high-risk MF resistant to or intolerant of ruxolitinib. The key objectives are safety, PD, changes in spleen volume (MRI/CT) and total symptoms scores (TSS) using the MPN-SAF instrument. Inclusion criteria included a platelet count >=100K/muL. Bone marrow (BM) biopsies and imaging studies (both centrally-read) were conducted at baseline and during washout (post-Day 84). The MPN-SAF was self-administered weekly. Phase 1/2a patients were treated for 84 days followed by a washout of up to 28 days. Patients demonstrating clinical benefit could resume treatment for additional 12 week cycles. Dosing was individually tailored using platelet count as a biomarker of effective thrombopoiesis. Patients were started at a presumed sub-therapeutic dose of 0.25 mg/kg/d and up-titrated weekly until the platelet count rested between 50 and 100K/muL. This
24. Evidence for a feline reservoir for dysgonic fermenter 2 keratitis
- Author
-
Paton, B G, primary, Ormerod, L D, additional, Peppe, J, additional, and Kenyon, K R, additional
- Published
- 1988
- Full Text
- View/download PDF
25. A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload.
- Author
-
Neufeld EJ, Galanello R, Viprakasit V, Aydinok Y, Piga A, Harmatz P, Forni GL, Shah FT, Grace RF, Porter JB, Wood JC, Peppe J, Jones A, and Rienhoff HY Jr
- Subjects
- Adolescent, Adult, Creatinine metabolism, Dose-Response Relationship, Drug, Ethyl Ethers adverse effects, Ethyl Ethers pharmacology, Female, Hemoglobinopathies complications, Hemoglobinopathies therapy, Humans, Iron analysis, Iron metabolism, Iron Chelating Agents adverse effects, Iron Chelating Agents pharmacology, Iron Overload diagnosis, Liver metabolism, Male, Middle Aged, Thiazoles adverse effects, Thiazoles pharmacology, Treatment Outcome, Young Adult, Ethyl Ethers therapeutic use, Iron Chelating Agents therapeutic use, Iron Overload drug therapy, Iron Overload etiology, Thiazoles therapeutic use, Transfusion Reaction
- Abstract
This was a 24-week, multicenter phase-2 study designed to assess safety, tolerability, and pharmacodynamics of FBS0701, a novel oral chelator, in adults with transfusional iron overload. Fifty-one patients, stratified by transfusional iron intake, were randomized to FBS0701 at either 14.5 or 29 mg/kg/d (16 and 32 mg/kg/d salt form). FBS0701 was generally well tolerated at both doses. Forty-nine patients (96%) completed the study. There were no drug-related serious adverse events. No adverse events (AEs) showed dose-dependency in frequency or severity. Treatment-related nausea, vomiting, abdominal pain, and diarrhea were each noted in < 5% of patients. Mean serum creatinine did not change significantly from Baseline or between dose groups. Transaminases wer increased in 8 (16%), three of whom acquired HCV on-study from a single blood bank while five had an abnormal baseline ALT. The 24 week mean change in liver iron concentration (ΔLIC) at 14.5 mg/kg/d was +3.1 mg/g (dw); 29% achieved a decrease in LIC. Mean ΔLIC at 29 mg/kg/d was -0.3 mg/g (dw); 44% achieved a decrease in LIC (P < .03 for ΔLIC between doses). The safety and tolerability profile at therapeutic doses compare favorably to other oral chelators.
- Published
- 2012
- Full Text
- View/download PDF
26. A new formulation of tolevamer, a novel nonantibiotic polymer, is safe and well-tolerated in healthy volunteers: a randomized phase I trial.
- Author
-
Peppe J, Porzio A, and Davidson DM
- Subjects
- Adolescent, Adult, Aged, Bacterial Proteins drug effects, Bacterial Toxins, Drug Administration Schedule, Humans, Male, Middle Aged, Sulfonic Acids, Treatment Outcome, Clostridioides difficile, Enterocolitis, Pseudomembranous drug therapy, Polymers administration & dosage
- Abstract
Aims: To evaluate the safety and tolerability of a new oral solution formulation of tolevamer potassium sodium, a nonantibiotic polymer that binds Clostridium difficile toxins A and B., Methods: This phase 1 randomized, double-blind, placebo-controlled study evaluated four doses of tolevamer potassium sodium in 40 healthy volunteers using a sequential dose escalation paradigm and doses of 6, 9, 12 and 15 g day(-1) for 9 days. Within each 10 patient cohort, eight patients received active treatment and two matching placebo. Placebo subjects were pooled to provide eight per arm. All subjects received three times daily dosing on days 2-8 as well as a loading dose (a single dose equal to the total daily dose) either on day 1 or day 9., Results: All 40 subjects completed the study per protocol. Treatment-emergent adverse events (TEAEs) were generally mild, transient, and resolved without sequelae. There were no serious AEs or deaths. There was no relationship detected between dose and the incidence of TEAEs, whether drug-related (all gastrointestinal disorders) or not. No clinically significant changes in laboratory parameters, including serum and urinary potassium concentrations, vital signs, and results of physical examination, were observed. A small but statistically significant reduction in 24 h urine potassium excretion was seen in the 15 g day(-1) dose group, and on day 10 in the 6 g day(-1) group., Conclusions: Tolevamer oral solution administered for 9 days at total daily doses up to 15 g, with loading doses of up to 15 g, was generally safe and well-tolerated in healthy volunteers.
- Published
- 2008
- Full Text
- View/download PDF
27. Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea.
- Author
-
Louie TJ, Peppe J, Watt CK, Johnson D, Mohammed R, Dow G, Weiss K, Simon S, John JF Jr, Garber G, Chasan-Taber S, and Davidson DM
- Subjects
- Adult, Aged, Aged, 80 and over, Anti-Infective Agents therapeutic use, Bacterial Proteins metabolism, Bacterial Toxins metabolism, Diarrhea drug therapy, Diarrhea microbiology, Double-Blind Method, Enterocolitis, Pseudomembranous microbiology, Enterotoxins metabolism, Female, Humans, Male, Middle Aged, Sulfonic Acids, Vancomycin therapeutic use, Clostridioides difficile, Enterocolitis, Pseudomembranous drug therapy, Ions therapeutic use, Polymers therapeutic use, Polystyrenes therapeutic use
- Abstract
Background: Current antibiotic therapies for Clostridium difficile-associated diarrhea have limitations, including progression to severe disease, recurrent C. difficile-associated diarrhea, and selection for nosocomial pathogens. Tolevamer, a soluble, high-molecular weight, anionic polymer that binds C. difficile toxins A and B is a unique nonantibiotic treatment option., Methods: In this 3-arm, multicenter, randomized, double-blind, active-controlled, parallel-design phase II study, patients with mild to moderately severe C. difficile-associated diarrhea were randomized to receive 3 g of tolevamer per day (n = 97), 6 g of tolevamer per day (n = 95), or 500 mg of vancomycin per day (n = 97). The primary efficacy parameter was time to resolution of diarrhea, defined as the first day of 2 consecutive days when the patient had hard or formed stools (any number) or < or = 2 stools of loose or watery consistency., Results: In the per-protocol study population, resolution of diarrhea was achieved in 48 (67%) of 72 patients receiving 3 g of tolevamer per day (median time to resolution of diarrhea, 4.0 days; 95% confidence interval, 2.0-6.0 days), in 58 (83%) of 70 patients receiving 6 g of tolevamer per day (median time to resolution of diarrhea, 2.5 days; 95% confidence interval, 2.0-3.0 days), and in 73 (91%) of 80 patients receiving vancomycin (median time to resolution of diarrhea, 2.0 days; 95% confidence interval, 1.0-3.0 days). Tolevamer administered at a dosage of 6 g per day was found to be noninferior to vancomycin administered at a dosage of 500 mg per day with regard to time to resolution of diarrhea (P = .02) and was associated with a trend toward a lower recurrence rate. Tolevamer was well tolerated but was associated with an increased risk of hypokalemia., Conclusions: Tolevamer, a novel polystyrene binder of C. difficile toxins A and B, effectively treats mild to moderate C. difficile diarrhea and merits further clinical development.
- Published
- 2006
- Full Text
- View/download PDF
28. Recovery of Bordetella holmesii from patients with pertussis-like symptoms: use of pulsed-field gel electrophoresis to characterize circulating strains.
- Author
-
Mazengia E, Silva EA, Peppe JA, Timperi R, and George H
- Subjects
- Bacterial Typing Techniques, Bordetella genetics, Bordetella isolation & purification, Bordetella bronchiseptica genetics, Bordetella bronchiseptica isolation & purification, Bordetella pertussis genetics, Bordetella pertussis isolation & purification, Humans, Molecular Epidemiology, Nasopharynx microbiology, Retrospective Studies, Whooping Cough blood, Whooping Cough epidemiology, Bordetella classification, Electrophoresis, Gel, Pulsed-Field, Polymorphism, Restriction Fragment Length, Whooping Cough microbiology
- Abstract
A 4-year retrospective study showing that we isolated Bordetella holmesii, but not Bordetella pertussis, from patients with pertussis-like symptoms was performed. From 1995 through 1998, we isolated B. holmesii from 32 nasopharyngeal specimens that had been submitted from patients suspected of having pertussis. Previously, B. holmesii had been associated mainly with septicemia and was not thought to be associated with respiratory illness. A study was undertaken to describe the characteristics of the B. holmesii isolates recovered and why we were successful in detecting the organism in nasopharyngeal specimens. B. holmesii isolates were characterized for drug sensitivities and for genetic relatedness by pulsed-field gel electrophoresis (PFGE). These isolates, an additional strain of B. holmesii isolated from a blood culture and previously confirmed by the Centers for Disease Control and Prevention, Atlanta, Ga., and 14 other clinical isolates of Bordetella spp., including 4 of B. bronchiseptica, 5 of B. parapertussis, and 5 of B. pertussis, were studied. They were all separately inoculated on three Bordet Gengou (BG) selective media containing either 0.625 microgram of oxacillin per ml, 40 microgram of cephalexin per ml, or 2.5 microgram of methicillin per ml, on BG agar with no antibiotic (control), and on charcoal agar (CA) with and without 40 microgram of cephalexin per ml. We found that cephalexin, the antibiotic commonly incorporated in both CA and BG agar for the recovery of Bordetella spp., is inhibitory to the growth of B. holmesii. In addition, the genotypic analysis of the 32 B. holmesii isolates by PFGE following restriction with XbaI and SpeI identified the dominant strains circulating during the study period.
- Published
- 2000
- Full Text
- View/download PDF
29. Pulsed-field gel electrophoresis of genomic digests demonstrates linkages among food, food handlers, and patrons in a food-borne Salmonella javiana outbreak in Massachusetts.
- Author
-
Lee R, Peppe J, and George H
- Subjects
- DNA, Bacterial analysis, Electrophoresis, Gel, Pulsed-Field, Humans, Massachusetts epidemiology, Disease Outbreaks, Food Handling, Food Microbiology, Salmonella isolation & purification, Salmonella Food Poisoning epidemiology
- Abstract
A total of 66 isolates of Salmonella javiana isolated from food, food handlers, and patrons that were epidemiologically linked to an outbreak of gastroenteritis were analyzed by pulsed-field gel electrophoresis. Analysis with restriction endonucleases XbaI and SpeI supported the epidemiologic association and suggested a pathway of transmission among food, food handlers, and patrons.
- Published
- 1998
- Full Text
- View/download PDF
30. Two Outbreaks of Salmonella enteritidis Associated with Monte Cristo Sandwiches.
- Author
-
Ridzon R, Kludt P, Peppe J, Sharifzadeh K, and Lett S
- Abstract
We report on two outbreaks of Salmonella enteritidis which occurred in 1992; both were associated with Monte Cristo sandwiches. The first outbreak, which occurred in Woods Hole, Massachusetts, was investigated as a case-control study, and involved 74 persons. The second outbreak, investigated as a cohort study, occurred in Brewster, Massachusetts, and involved 32 persons. Monte Cristo sandwiches were strongly implicated in both outbreaks; the odds ratio in the case-control study was 43, and the relative risk in the cohort study was 13. Food-preparation procedures were reviewed and food handlers were educated about safe food-preparation practices. Because of the short grilling time for Monte Cristo sandwiches, (usually several minutes) the eggs used in the preparation may only be partially cooked. As a result, this food should be viewed as high risk for S. enteritidis . Pasteurized eggs should be used to prepare Monte Cristo sandwiches, especially in a commercial setting.
- Published
- 1997
- Full Text
- View/download PDF
31. Compulsivity and superstitiousness.
- Author
-
Frost RO, Krause MS, McMahon MJ, Peppe J, Evans M, McPhee AE, and Holden M
- Subjects
- Adult, Female, Humans, Obsessive-Compulsive Disorder diagnosis, Obsessive-Compulsive Disorder psychology, Personality Inventory, Compulsive Behavior psychology, Superstitions
- Abstract
The relationship between superstitious beliefs and behaviors, and measures of obsessive-compulsive experiences was examined in this study. Both superstitious beliefs and superstitious behaviors were correlated with measures of compulsivity and obsessionality. Compulsive checking, but not compulsive cleaning (from the MOCI and the CAC-R) were correlated with superstitiousness. Both subscales from the Obsessional Thoughts Questionnaire were correlated with superstitiousness. The implications of these findings for the role of perceived control in obsessive-compulsive phenomena were discussed.
- Published
- 1993
- Full Text
- View/download PDF
32. Pertussis outbreaks in groups claiming religious exemptions to vaccinations.
- Author
-
Etkind P, Lett SM, Macdonald PD, Silva E, and Peppe J
- Subjects
- Adolescent, Adult, Anti-Bacterial Agents therapeutic use, Child, Child, Preschool, Family Health, Humans, Infant, Massachusetts epidemiology, Middle Aged, Whooping Cough transmission, Disease Outbreaks, Religion and Medicine, Vaccination statistics & numerical data, Whooping Cough epidemiology, Whooping Cough prevention & control
- Abstract
Four recent outbreaks of pertussis in Massachusetts illustrate some features that contribute to the increased incidence of the disease. The outbreaks involved unimmunized groups of children with philosophical or religious exemptions from school or day-care immunization requirements and children and adults who were reluctant to undergo antibiotic prophylaxis or therapy. Parents and physicians should be aware that failure to immunize and to cooperate in follow-up preventive measures can have public health and potential medicolegal repercussions.
- Published
- 1992
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.